DYN Competitors & Alternatives
Compare Dyne Therapeutics Inc with similar stocks in the same industry
Biotechnology
DYN
Main Stock$20.26
Tradestie Score
62
Market Cap
$1.78B
Analyst Upside
+88.8%
Top Competitors
224 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
LGND
Ligand Pharmaceuticals Inc.
|
$279.44
|
$3.49B | 35.7 | 64 | Compare |
|
TLX
Telix Pharmaceuticals Limited American Depositary Shares
|
$10.21
|
$3.40B | - | 55 | Compare |
|
QURE
uniQure N.V.
|
$49.04
|
$3.39B | - | 63 | Compare |
|
SRRK
Scholar Rock Holding Corporation Common Stock
|
$51.27
|
$3.33B | - | 62 | Compare |
|
NAMS
NewAmsterdam Pharma Company N.V. Ordinary Shares
|
$31.40
|
$3.31B | - | 50 | Compare |
|
SLNO
Soleno Therapeutics, Inc. Common Stock
|
$53.01
|
$3.20B | 27.5 | 49 | Compare |
|
MLYS
Mineralys Therapeutics, Inc. Common Stock
|
$25.61
|
$3.09B | - | 54 | Compare |
|
VKTX
Viking Therapeutics, Inc
|
$34.81
|
$3.08B | - | 65 | Compare |
|
CNTA
Centessa Pharmaceuticals plc American Depositary Shares
|
$40.50
|
$3.03B | - | 61 | Compare |
|
XENE
Xenon Pharmaceuticals Inc
|
$54.61
|
$3.02B | - | 67 | Compare |
More DYN Analysis
Data updated: Jun 23, 2026 | Industry: Biotechnology (SIC 2834)
224 stocks in this industry